Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway

INTRODUCTION: The beneficial effect of amarogentin in the management of osteoporosis was determined using in vivo and in vitro methods. MATERIAL AND METHODS: Experimental osteoporosis was induced in rats via bilateral ovariectomy. Rats were then treated for 5 weeks with amarogentin (50 and 100 mg/kg...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sirui, Li, Xianlong, He, Feng, Jiao, Rui, Zhang, Song, Li, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Experimental Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074178/
https://www.ncbi.nlm.nih.gov/pubmed/37034504
http://dx.doi.org/10.5114/aoms.2019.89652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074178/
https://www.ncbi.nlm.nih.gov/pubmed/37034504
http://dx.doi.org/10.5114/aoms.2019.89652

Ejemplares similares